Menu

Back to Directory

Pulmonary Nodules

Pulmonary nodules are small spots on the lung found on chest imaging. Most are benign scars or healed infections, but some need CT follow-up or biopsy to rule out early lung cancer.

Pulmonary nodules are small, rounded spots in the lung — generally under 3 centimeters across — discovered on a chest X-ray or CT scan, usually done for another reason. Nodules are extremely common — they turn up on a large share of chest CT scans, and the vast majority of small ones are benign. Finding a "spot on the lung" is understandably frightening, but a nodule is a finding, not a diagnosis. The purpose of structured follow-up is to identify the few nodules that represent early lung cancer, at the stage when treatment is most successful, while sparing everyone else unnecessary procedures.

Causes

  • Healed infections: The most common cause — old fungal or bacterial infections and tuberculosis leave small scars or calcified granulomas that persist for life.
  • Benign growths: Hamartomas and other noncancerous tumors.
  • Inflammatory conditions: Diseases such as sarcoidosis and rheumatoid disease — a form of inflammatory arthritis — can produce lung nodules.
  • Cancer: A minority of nodules are early lung cancers or, less often, cancer that has spread from elsewhere. The likelihood rises with older age, a long smoking history, larger nodule size, irregular edges, and growth over time.

How Nodules Are Evaluated

The first step is comparing with any older imaging: a nodule unchanged for two or more years is almost always benign. When no prior images exist, your doctor estimates the probability of cancer based on your age, smoking history, and the nodule's size, shape, and location:
  • Small, low-risk nodules: Followed with periodic CT scans — typically at intervals of 3 to 12 months — to confirm they are not growing. Many need only one or two follow-up scans before monitoring can stop.
  • Intermediate nodules: May warrant a PET scan, which highlights metabolically active tissue suggestive of cancer or active inflammation.
  • Larger or suspicious nodules: Evaluated with biopsy — by bronchoscopy or a needle through the chest wall — or surgical removal.
Features that reassure doctors include small size, smooth round edges, central calcification, and stability over time. Features that raise concern include size over about 8 millimeters, spiculated or irregular borders, location in an upper lobe, and any measurable growth between scans. Your doctor weighs all of these together rather than reacting to any single detail.

Follow-Up and Prevention

The single most important step is completing the recommended follow-up scans; nodules that are ignored cannot be judged stable. Quitting smoking dramatically lowers future lung-cancer risk, and structured support for nicotine dependence doubles the odds of quitting successfully. Adults aged 50 to 80 with a significant smoking history should also ask about annual low-dose CT lung-cancer screening, which finds cancers at a curable stage and often detects nodules that then simply need scheduled follow-up. People with chronic lung disease such as COPD merit particularly careful attention, since their baseline cancer risk is higher.

When to Seek Care

Contact your doctor promptly if you have a known nodule and develop a new persistent cough, coughing up blood, unexplained weight loss, hoarseness, or chest pain — and never skip a scheduled surveillance scan, even if you feel entirely well. Keeping track of scan intervals and comparing images over the years takes organized, ongoing care. The internal-medicine team at Zimmer Medical Group manages nodule surveillance, coordinates pulmonology referrals when needed, and handles lung-cancer screening — schedule a visit to review your imaging and plan.

What Happens After a Nodule Is Found

Most pulmonary nodules are found by accident, on a scan ordered for something else entirely, and the great majority are benign — old infections, scarring, or small collections of inflammatory tissue that have been there for years. Being told a spot has been seen on your lung is nonetheless alarming, and the gap between that moment and the follow-up scan is where most of the distress lives.

Why the answer is usually to wait and rescan

Size and stability are what distinguish benign from concerning, and stability can only be demonstrated over time. A nodule that has not changed across two years of imaging is almost certainly benign, which is why surveillance intervals are set by size and risk rather than by anxiety. Biopsying every small nodule would cause more harm through pneumothorax and unnecessary surgery than it would prevent, and that is the reasoning behind a schedule that can feel passive.

What raises or lowers concern

Larger size, irregular or spiculated margins, upper-lobe location, growth between scans, smoking history, older age, and a history of cancer all raise concern. Small size, smooth margins, calcification in a benign pattern, and no change over time lower it. Finding old imaging from years earlier is frequently the single most useful step, because a nodule visible and unchanged on a scan from a decade ago needs no further work at all.

Screening is a different situation from an incidental finding

Low-dose CT screening for adults with a significant smoking history is a deliberate search that detects lung cancer early enough to treat, and it reduces mortality. That is distinct from a nodule found incidentally, though the follow-up principles overlap. If you meet screening criteria and have never been screened, that conversation is worth having separately. Our pulmonary team manages both, and the COPD and nicotine dependence pages cover the related risk factors. The National Cancer Institute and the American Lung Association both publish patient-level guidance.

Managing the wait

The interval between scans is genuinely difficult, and it helps to know the whole plan rather than only when the next appointment falls. Ask what size the nodule is, what the full follow-up schedule looks like, and what would change it. Patients who understand that a stable nodule at two years ends the surveillance entirely find the intervening scans considerably easier than those who assume the monitoring continues indefinitely.

If you have been told you have a nodule and are unclear what the follow-up plan is, contact us — knowing the interval and having it scheduled removes most of the uncertainty.

Frequently Asked Questions

Almost always no. The large majority of pulmonary nodules are benign — old infection, scarring, or inflammatory tissue. Size, appearance, growth over time, and your risk factors determine how much concern is warranted, and most need only interval imaging.
Because stability over time is the most reliable evidence a nodule is benign, and it cannot be demonstrated any faster. Biopsying every small nodule would cause more harm through procedure complications than it would prevent.
Considerably. A nodule that appears unchanged on imaging from several years ago is almost certainly benign and may need no further follow-up. Tracking down prior imaging from another hospital or state is often the highest-value step available.
If you are between 50 and 80 with a 20 pack-year smoking history and currently smoke or quit within the past 15 years, yes — annual low-dose CT screening reduces lung cancer mortality. That is a separate question from an incidentally found nodule.

Related Medications

Treatment for this condition is tailored to the individual. Browse the medication directory or schedule a visit to discuss options.

Keep exploring care topics from Zimmer Medical Group.